Epistem Announces the Successful Evaluation of New RNA-AMP™ Technology
News Feb 13, 2015
Epistem Holdings Plc has announced the successful evaluation of RNA-Amp™ for single cell expression profiling. The results have been published in BMC Genomics (Rothwell et al. (2014). 15:1129) and compare amplified cDNA derived from three RNA-Amplification kits (Miltenyi MACS™, NuGEN Ovation® One-Direct and Epistem RNA-Amp™). The authors concluded that Epistem's RNA-Amp™ kit exhibited the highest sensitivity and reproducibility.
In addition, Affymetrix microarray data demonstrated that cDNA generated from single cells using Epistem RNA-Amp™ produced faithful representative cDNA relative to unamplified reference controls. Strong platform correlations were also reported following the assessment of RNA-Amp™ cDNA by RNA-Seq and high density qPCR.
Using RNA-Amp™ amplified material, the authors were able to identify transcriptional differences in cancer initiating cells (CICs) following RNA-Seq analysis. The authors concluded that the combined results confirmed the sensitivity and reproducibility of the Epistem RNA-Amp™ technology for profiling in small cell populations.
Epistem's RNA-Amp™ technology is a highly sensitive and reproducible method to derive cDNA from picogram to nanogram quantities of RNA. RNA-Amp™ can be used with samples containing extracted RNA or performs well with samples directly, without the need for RNA isolation.
The amplified cDNA derived from Epistem kits is platform agnostic and can be used in conjunction with a range of instrument manufacturer's microarray, RT-qPCR and Next Generation Sequencing products. Epistem will be presenting the RNA-Amp™ technology at the Molecular Medicine Tri-Conference in San Francisco 15-20th February.
Matthew Walls, Epistem CEO commented; "We are delighted with the results of the evaluation study which alongside our existing internal applications in biomarker discovery and key gene regulation, opens up the possibility of producing RNA Amp™ in a kit form for Next Generation Sequencing."
The Ancient Behaviour of Sleep, Conserved Throughout EvolutionNews
The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE
Genetic Code of Neuronal Communication Determines Cell TypeNews
The findings should help scientists sort out the bewildering array of neurons that are intertwined in the brain.READ MORE